-+ 0.00%
-+ 0.00%
-+ 0.00%

VTV THERAPEUTICS INC - TOPLINE PHASE 3 DATA FOR CADISEGLIATIN EXPECTED IN 2H 2026

Reuters·05/15/2025 20:01:01

Please log in to view news